Association between apolipoprotein E genetic polymorphism and the development of diabetic nephropathy in type 2 diabetic patients

Diabetes Research and Clinical Practice

Volumn 77, Issue 3 SUPPL., 2007, Pages

  Kwon, Mi Kwang ^a   Rhee, Sang Youl ^a   Chon, Suk ^a   Oh, Seungjoon ^a   Woo, Jeong taek ^a   Kim, Sung Woon ^a   Kim, Jin Woo ^a   Kim, Young Seol ^a   Jeong, Kyung Hwan ^a   Lee, Sang Ho ^a   Lee, Tae won ^a   Ihm, Chun Gyoo ^a  

^a Kyung Hee University Hospital   (South Korea)

Author keywords

Apolipoprotein E; Diabetic nephropathy; Dyslipidemia; Microalbuminuria; Type 2 diabetic patients

Indexed keywords

APOLIPOPROTEIN E; CHOLESTEROL; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN A1C; TRIACYLGLYCEROL;

ADULT; AGED; ALLELE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIABETIC PATIENT; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; DYSLIPIDEMIA; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HYPERTENSION; KIDNEY FUNCTION; LOGISTIC REGRESSION ANALYSIS; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; REAL TIME POLYMERASE CHAIN REACTION; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL;

AGED; APOLIPOPROTEINS E; BODY MASS INDEX; CHOLESTEROL; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; GENOTYPE; HETEROZYGOTE DETECTION; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; REFERENCE VALUES; TRIGLYCERIDES;

EID: 34547678074     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2007.03.009     Document Type: Article

References (25)

1. Ravid M., Brosh D., Ravid-Safran D., Levy Z., and Rachmani R. Main risk factors for nephropathy in type 2 diabetes mellitus are plasma cholesterol levels, mean blood pressure, and hyperglycemia. Arch. Intern. Med. 158 (1998) 998-1004
2. Kimura H., Suzuki Y., Gejyo F., Karasawa R., Miyajaki R., Suzuki S., et al. Apolipoprotein E4 reduces risk of diabetic nephropathy in patients with NIDDM. Am. J. Kidney Dis. 31 (1998) 666-673
3. Liberopoulos E., Siamopoulos K., and Elisaf M. Apolipoprotein E and renal disease. Am. J. Kidney Dis. 43 (2004) 223-233
4. Bonnet F., and Cooper M.E. Potential influence of lipids in diabetic nephropathy: insights from experimental data and clinical studies. Diab. Metab. 26 (2000) 254-264
5. Dogra G., and Watts G.F. Genes and diabetic nephropathy: what have we learnt so far?. Pract. Diab. Int. 17 (2000) 84-90
6. Liberopoulos E.N., Miltiadous G.A., Cariolou M., Tselepis A.D., Siamopoulos K.C., and Elisaf M.S. The influence of serum apolipoprotein E concentration and polymorphism on serum lipid parameters in hemodialysis patients. Am. J. Kidney Dis. 44 (2004) 300-308
7. Mahley R.W. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 240 (1988) 622-629
8. Rippin J.D., Patel A., and Bain S.C. Genetics of diabetic nephropathy. Best Pract. Res. Clin. Endocrinol. Metab. 15 (2001) 345-358
9. Akarsu E., Pirim I., Capoglu L., Kaya H., Akcay G., and Unuvar N. A relation between the apolipoprotein E genotypes and microalbuminuria in type 2 diabetes mellitus. Turk. J. Med. Sci. 31 (2001) 59-64
10. Ha S.K., Park H.S., Kim K.W., Kim S.J., Kim D.H., Kim J.H., et al. Association between apolipoprotein E polymorphism and macroalbuminuria in patients with non-insulin dependent diabetes mellitus. Nephrol. Dial. Transpl. 14 (1999) 2144-2149
11. Hsieh M.C., Lin S.R., Yang Y.C., Chen H.C., Lin J.N., and Shin S.J. Higher frequency of apolipoprotein E2 allele in type 2 diabetic patients with nephropathy in Taiwan. J. Nephrol. 15 (2002) 368-373
12. Eto M., Saito M., Okada M., Kume Y., Kawasaki F., Matsuda M., et al. Apolipoprotein E genetic polymorphism, remnant lipoproteins, and nephropathy in type 2 diabetic patients. Am. J. Kidney Dis. 40 (2002) 243-251
13. Park J.S., Nam J.Y., Kim C.S., Kim D.M., Cho M.H., Park J., et al. Apolipoprotein E genetic polymorphism and diabetic microangiopathy in type 2 diabetic patients. J. Kor. Diab. Assoc. 28 (2004) 511-520
14. Hsu C.C., Linda Kao W.H., Coresh J., Pankow J.S., Marsh-Manzi J., Boerwinkle E., et al. Apolipoprotein E and progression of chronic kidney disease. JAMA 293 (2005) 2892-2899
15. Araki S.I., Isono M., Koya D., Kikkawa R., Makiishi T., Kashiwaki A., et al. APOE polymorphism and the progression of diabetic nephropathy in Japanese subjects with type 2 diabetes; Results of a prospective observational follow-up study. Diab. Care 26 (2003) 2416-2420
16. Boize R., Benhamou P.Y., Corticeli P., Valenti K., Bosson J.L., and Halmi S. Apo E polymorphism and albuminuria in diabetes mellitus: a role for LDL in the development of nephropathy in NIDDM. Nephrol. Dial. Transpl. 13 (1998) 72-75
17. Roussos L., Ekstrom U., Ehle P.N., Oqvist B., and Floren C.H. Apolipoprotein E polymorphism in 385 patients on renal replacement therapy in Sweden. Scand. J. Urol. Nephrol. 38 (2004) 504-510
18. Joss N., Jardine A., Gaffney D., and Boulton-Jones J.M. Influence of apolipoprotein E genotype on progression of diabetic nephropathy. Nephron Exp. Nephrol. 101 (2005) 127-133
19. Onuma T., Laffel L.M.B., Angelico M.C., and Krolewski A.S. Apolipoprotein E genotypes and risk of diabetic nephropathy. J. Am. Soc. Nephrol. 7 (1996) 1075-1078
20. Shcherbak N.S. Apolipoprotein E gene polymorphism is not a strong risk factor for diabetic nephropathy and retinopathy in type 1 diabetes: case-control study. BMC Med. Genet. 2 (2001) 8-12
21. Hallman D.M., Boerwinkle E., Saha N., Sandholzer C., Menzel H.J., Csazar A., et al. The apolipoprotein E polymorphism: a comparison of allele frequencies and effects in nine populations. Am. J. Hum. Genet. 49 (1991) 338-349
22. Kim J.H., Lee E.J., and Kwon O.H. Apolipoprotein E genotyping and phenotyping in type II diabetes mellitus patients with hypertriglyceridemia. Clin. Biochem. 30 (1997) 47-52
23. Liu L., Xiang K., Zheng T., Zhang R., Li M., and Li J. Co-inheritance of specific genotypes of HSPG and Apo E gene increases risk of type 2 diabetic nephropathy. Mol. Cell. Biochem. 254 (2003) 353-358
24. Horita K., Eto M., and Makino I. Apolipoprotein E2, renal failure and lipid abnormalities in non-insulin dependent diabetes mellitus. Atherosclerosis 107 (1994) 203-211
25. Chen G., Paka L., Kako Y., Singhal P., Duan W., and Pillarisetti S. A prospective role for kidney apolipoprotein E. Regulation of mesangial cell proliferation and matrix expansion. J. Biol. Chem. 276 (2001) 49142-49147